Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Survey of Foot and Leg Chronic Wounds Followed up to 20 Weeks After Initiation of CACIPLIQ20® add-on to Optimal Local Care

NCT05170984 is registered in ClinicalTrials.gov with Organ, Tissue, Regeneration, Repair and Replacement as lead sponsor.

NCT NCT05170984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05170984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Survey of Foot and Leg Chronic Wounds Followed up to 20 Weeks After Initiation of CACIPLIQ20® add-on to Optimal Local Care
Lead sponsor
Organ, Tissue, Regeneration, Repair and Replacement
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2022
Completion date
December 30, 2024
Enrollment
191 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial ulcer, chronic ulcer of leg or foot, diabetic foot ulcer, venous ulcer of leg